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Abstract
Radiation risks are estimated in a competing risk formalism where age or time after exposure 
estimates of increased risks for cancer and circulatory diseases are folded with a probability to 
survive to a given age. The survival function, also called the life-table, changes with calendar year, 
gender, smoking status and other demographic variables. An outstanding problem in risk 
estimation is the method of risk transfer between exposed populations and a second population 
where risks are to be estimated. Approaches used to transfer risks are based on: 1) Multiplicative 
risk transfer models - proportional to background disease rates. 2) Additive risk transfer model -
risks independent of background rates. In addition, a Mixture model is often considered where 
the multiplicative and additive transfer assumptions are given weighted contributions. 
We studied the influence of the survival probability on the risk of exposure induced cancer and 
circulatory disease morbidity and mortality in the Multiplicative transfer model and the Mixture 
model.  Risks for never-smokers  (NS) compared to the average U.S. population are estimated to 
be reduced between 30% and 60% dependent on model assumptions.  Lung cancer is the major 
contributor to the reduction for NS, with additional contributions from circulatory diseases and 
cancers of the stomach, liver, bladder, oral cavity, esophagus, colon, a portion of the solid cancer 
remainder, and leukemia. Greater improvements in risk estimates for  NS’s are possible, and would 
be dependent on improved understanding of risk transfer models, and elucidating the role of 
space radiation on the various stages of disease formation (e.g. initiation, promotion, and 
progression).
Methods
ESTIMATING RADIATION RISKS:
The cancer radiation risks for never-smokers (NS) were considered by Cucinotta et al (2011) in 
both a Radiation Research article and a NASA publication.  The cancer models considered here 
implement the NASA 2010 Risk projection models which include model fits from BEIR VII, 
UNSCEAR 2006, and Preston (2007).  We compare the multiplicative risk transfer models and the 
mixture model .  We have also added coronary heart disease (CHD) and stroke radiation risks as 
estimated by Preston (2003).
ESTIMATING NEVER-SMOKER (NS) RATES:
US average rates and life tables are available online from the Centers for Disease Control’s 
website.  Thun et al. provides a detailed review of lung cancer rates for NS with estimates (2008).  
Malarcher et al. provides Age-specific relative risks (RR) for the four leading causes of smoking 
related deaths; lung cancer, CHD, stroke, and chronic obstructive pulmonary disease (COPD).  We 
can estimate NS rates using the US average rates and these age-specific relative risks.  For the less 
studied cancers, overall RR can be used to estimate the NS rates.  The RR estimates used are 
reported in Table 1.  In Figure 3, we compare the estimates provided by Thun to the methods of 
estimating NS rates using RR. The Non-smoker lung cancer rates reported by Thun et al. and the 
NS cancer rates estimated using age specific RR risks have similar shapes, but slightly different 
absolute values.  Overall estimates using RR risks approximate the NS rates fairly well with less 
accuracy at older ages.  The survival function for NS will be adjusted using the NS mortality rates 
for lung cancer, smoking sensitive cancers, CHD, stroke, and COPD.  
Discussion
Astronaut Kaplan-Meyer (KM) estimates for different demographics  of US astronauts and payload 
specialists (PS) are shown in Figures 1A-B.  There was data available for 339 astronauts with 44 
deaths, and 23 PS with one death.  296 of the astronauts were male (M) and 40 were female (F). 
In Figure 1A, you can see that there is no significant differences between M, F, and PS, and all 
combined data.  The low  F and PS frequencies provide little power for statistical testing of 
differences.  18 of the deaths were work related and would not compare well with the average US 
population. For comparison these deaths were also censored at the time of the work related 
death.  Figure 1B, shows how censoring the work related deaths changes the survival curve.  
Figure 1C and 1D compares the overall astronaut KM curve to the M and F US average and NS 
survival estimates.  When the work related deaths are included, the survival probability has a dip 
between ages 30 and 60 that is not seen in the average US population.  However when we 
account for work related deaths, the survival curve is similar to the NS female survival.  This 
improvement over NS male survival could be due to factors such as obesity and socioeconomic 
factors that are not accounted for in the NS survival.  
Because the astronaut survival curve  was similar to the NS female survival, when calculating % 
REID we also compared  males using female NS survival estimates and kept the male NS rates the 
same.  Figure 2 shows comparisons for %REID per 1 Sv for multiplicative and mixture models.  For 
lung cancer and all cancers, there are large improvements in %REID for female NS.  Using a 
multiplicative model also improves the %REID for NS.  There is less of an improvement in %REID 
for male NS.  For CHD and stroke %REID, the longer survival due to NS cancer improvements 
creates slightly larger CHD and stroke risks.  When M survival is improved further to the NS female 
survival, there is a larger increase in risk for CHD and stroke.  Overall improvements in risk are 
seen when we account for smoking status. 
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Males RR-Smoker RR-Former RR-NS RR(NS/US)
Esophagus 6.76 4.46 1 0.27
Stomach 1.96 1.47 1 0.71
Bladder 3.27 2.09 1 0.50
Oral Cavity 10.89 3.4 1 0.23
Liver 2.25 1.75 1 0.63
Colon 1.19 1.21 1 0.89
Leukemia 2 1.5 1 0.69
Remainder 4 2.5 1 0.43
Lung cancer
35-59 27.21 11.09 1 0.09
60-69 30.71 11.25 1 0.08
70-79 27.23 9.43 1 0.09
80+ 13.4 6.55 1 0.16
Age-adjusted 23.26 8.7 1 0.11
CHD
35-59 3.36 1.99 1 0.51
60-69 2.06 1.44 1 0.70
70-79 1.49 1.19 1 0.84
80+ 1.23 1.04 1 0.93
Age-adjusted 2.68 1.72 1 0.59
Stroke
35-59 3.64 1.12 1 0.59
60-69 2.48 1.19 1 0.70
70-79 1.77 1.15 1 0.80
80+ 1.09 0.81 1 1.06
Age-adjusted 2.97 1.12 1 0.66
COPD
50-69 13.57 11.18 1 0.12
70+ 9.76 7.43 1 0.18
Age-adjusted 12.4 10 1 0.14
Females RR-Smoker RR-Former RR-NS RR(NS)/US
Esophagus 7.75 2.79 1 0.35
Stomach 1.36 1.32 1 0.85
Bladder 2.22 1.89 1 0.65
Oral Cavity 5.08 2.29 1 0.46
Liver 2.25 1.75 1 0.67
Colon 1.28 1.23 1 0.88
Leukemia 2 1.5 1 0.74
Remainder 4 2.5 1 0.48
Lung cancer
35-59 14.77 4.53 1 0.21
60-69 14.7 5.05 1 0.20
70-79 11.28 4.5 1 0.25
80+ 7.31 2.95 1 0.35
Age-adjusted 12.69 4.53 1 0.23
CHD
35-59 3.61 1.61 1 0.59
60-69 2.43 1.14 1 0.77
70-79 1.63 1.18 1 0.85
80+ 1.34 0.99 1 0.95
Age-adjusted 2.7 1.38 1 0.69
Stroke
35-59 6.34 1.33 1 0.48
60-69 2.64 1.22 1 0.73
70-79 2.22 1.22 1 0.77
80+ 0.59 0.75 1 1.19
Age-adjusted 3.82 1.23 1 0.63
COPD
50-69 12.29 8.26 1 0.18
70+ 8.92 5.94 1 0.24
Age-adjusted 10.96 7.34 1 0.20
Figure 1. Comparison on estimated survivor functions conditional on surviving to age 30.  Astronaut survival estimated 
using Kaplan-Meier estimates.  US average and never-smokers (NS) estimates based on US 2005 life tables.
Table 1. Estimates of relative risks (RRs) for never-smokers (NS) compared to US average population for several
cancers attributable to smoking, coronary heart disease (CHD), stroke, and chronic obstructive pulmonary disease
(COPD). For males, current smokers, former smokers, and NS are estimated at 24%, 40%, and 36% of the
population. For females, we use 18%, 35%, and 47% of the population.
Figure 2. Comparison of %REID per Sv for males and females
as a function of age at exposure for mixture model and
multiplicative model for the US average population and never-
smokers (NS) adjusted population.
Figure 3. Comparison on age-specific cancer
incidence and mortality rates for the 2005 US
average population, recent analysis for never-
smokers (NS) by Thun et al, NS rates estimated
using relative risks (RR), and NS rates estimated
using age-specific RR.
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